ECOG-ACRIN Cancer Research Group

The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) is a multidisciplinary, membership-based scientific organization that designs and conducts biomarker-driven cancer research involving adults who have or are at risk of developing cancer. ECOG-ACRIN consists of a headquarters location in Philadelphia, and several fully staffed centers and offices, all of which oversee the governance, operations, membership, and scientific programs of the Group. These include two biostatistics and data management centers located at the Dana-Farber Cancer Institute, Boston and Brown University, Providence, R.I., a central biorepository and pathology facility located at The University of Texas MD Anderson Cancer Center, Houston, and an operations office in Boston. Together these centers and offices serve nearly 1100 member institutions in the U.S. and around the world. Approximately 12,000 physicians, translational scientists, and associated research professionals from the member institutions are involved in Group research, which is organized into three scientific programs: Cancer Control and Outcomes, Therapeutic Studies, and Biomarker Sciences. These three distinct—yet complementary—scientific programs accommodate the Group’s expansive research portfolio, as well as the size, diversity, and multidisciplinary nature of its membership.